DECREASING PATTERNS OF INFLIXIMAB TROUGH LEVELS IN ASYMPTOMATIC INFLAMMATORY BOWEL DISEASE PATIENTS UNDER MAINTENANCE TREATMENT WITH INFLIXIMAB; DOES IT MATTER?

被引：0
|
作者：
Orfanoudaki, Eleni
Gazouli, Maria
Foteinogiannopoulou, Kalliopi
Theodoraki, Eirini
Legaki, Evangelia
Koutroubakis, Ioannis E.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1890
引用
收藏
页码：S467 / S467
页数：1
相关论文
共 50 条
  • [1] Infliximab trough levels are decreasing overtime in patients with inflammatory bowel disease on maintenance treatment with infliximab
    Orfanoudaki, E.
    Gazouli, M.
    Foteinogiannopoulou, K.
    Theodouraki, E.
    Legaki, E.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S330 - S331
  • [2] Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab
    Orfanoudaki, Eleni
    Gazouli, Maria
    Foteinogiannopoulou, Kalliopi
    Theodoraki, Eirini
    Legaki, Evangelia
    Romanos, Ioannis
    Mouzas, Ioannis
    Koutroubakis, Ioannis E.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (02) : 187 - 191
  • [3] Predictive value of infliximab trough levels in quiescent inflammatory bowel disease under maintenance infliximab therapy
    Bejaoui, M.
    Charbit-Henrion, F.
    Landman, C.
    Sokol, H.
    Bourrier, A.
    Nion-Larmurier, I.
    Cosnes, J.
    Beaugerie, L.
    Seksik, P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S396 - S396
  • [4] Long-term impact of the decrease of infliximab trough levels on the disease course in Inflammatory Bowel Disease patients under maintenance treatment with infliximab
    Orfanoudaki, E.
    Gazouli, M.
    Foteinogiannopoulou, K.
    Theodoraki, E.
    Legaki, E.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S375 - S376
  • [5] Infliximab trough levels during maintenance are predictive for infliximab efficacy in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Hoffman, I.
    Dreesen, E.
    Ferrante, M.
    Gils, A.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S180 - S181
  • [6] Therapeutic thresholds for infliximab trough levels during maintenance treatment in patients with inflammatory bowel disease
    Rasmussen, M.
    Brynskov, J.
    Ainsworth, M. A.
    Buhl, S.
    Bendtzen, K.
    Steenholdt, C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S409 - S409
  • [7] Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy
    Parra, Rogerio S.
    Feitosa, Marley R.
    Ribeiro, Leticia C. H.
    Castro, Lais A.
    Rocha, Jose J. R.
    Feres, Omar
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [8] Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment
    Rolandsdotter, Helena
    Marits, Per
    Sundin, Ulf
    Wikstrom, Ann-Charlotte
    Fagerberg, Ulrika L.
    Finkel, Yigael
    Eberhardson, Michael
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03):
  • [9] Clinical Use of Infliximab Trough Levels and Antibodies to Infliximab in Pediatric Patients With Inflammatory Bowel Disease
    Merras-Salmio, Laura
    Kolho, Kaija-Leena
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 64 (02): : 272 - 278
  • [10] ANTIBODIES TO INFLIXIMAB AND INFLIXIMAB TROUGH LEVELS IN THE MANAGEMENT OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE
    Dilillo, A.
    Isoldi, S.
    Mallardo, S.
    Civitelli, F.
    Oliva, S.
    Aloi, M.
    Rossi, P.
    Carbogno, S.
    Viola, F.
    Cucchiara, S.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E271 - E271
12345